IPO registrations (S-1, F-1) · Registrants
Vericel Corp
- SEC CIK
- 887359 · filings on EDGAR ↗
- Name on the registration
- AASTROM BIOSCIENCES INC
- Former names
- AASTROM BIOSCIENCES INC (1996–2014)
- Registration
- Form S-1, first filed 1996-11-01, last 2014-09-08; 6 initial registrations, 19 amendments
- Outcome
- Final prospectus filed 1997-02-04; declared effective 2008-11-24
- Industry (SIC)
- Biological Products, (No Diagnostic Substances) 2836
- Incorporated in
- MI
- Business address
- 25 BLUE SKY DRIVE, Burlington, MA 01803
- EIN
- 94-3096597
- Ticker
- VCEL (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- Vericel Corp on the corporate pages
On this site
- Business registration: VERICEL CORPORATION EXACT (EIN (EXACT, as the state registration reports it))
- Business registration: Vericel Corporation Fuzzy (name and state)
- Business registration: VERICEL CORPORATION Fuzzy (name and state)
- Business registration: VERICEL CORPORATION Fuzzy (name and state)
- Business registration: VERICEL CORPORATION Fuzzy (name and state)
- Form 5500 plan sponsor: VERICEL CORPORATION EXACT (EIN (EXACT))
- Federal award recipient: VERICEL CORPORATION Fuzzy (name and state)
- Form D issuer: AASTROM BIOSCIENCES INC EXACT (CIK (EXACT))
- SEC filer: AASTROM BIOSCIENCES INC EXACT (CIK (EXACT))
Filings 43
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 1996-11-01 | S-1 | S-1 (registration) | AASTROM BIOSCIENCES INC | 0000950130-96-004174 ↗ |
| 1996-11-18 | S-1/A | S-1/A (amendment) | AASTROM BIOSCIENCES INC | 0001017062-96-000579 ↗ |
| 1996-12-20 | S-1/A | S-1/A (amendment) | AASTROM BIOSCIENCES INC | 0000898430-96-005817 ↗ |
| 1997-01-07 | S-1/A | S-1/A (amendment) | AASTROM BIOSCIENCES INC | 0001017062-97-000006 ↗ |
| 1997-01-28 | S-1/A | S-1/A (amendment) | AASTROM BIOSCIENCES INC | 0001017062-97-000095 ↗ |
| 1997-01-29 | S-1/A | S-1/A (amendment) | AASTROM BIOSCIENCES INC | 0001017062-97-000105 ↗ |
| 1997-01-30 | S-1/A | S-1/A (amendment) | AASTROM BIOSCIENCES INC | 0001017062-97-000108 ↗ |
| 1997-02-04 | 424B1 | 424B1 (final prospectus) | AASTROM BIOSCIENCES INC | 0001017062-97-000128 ↗ |
| 1997-10-08 | S-1 | S-1 (registration) | AASTROM BIOSCIENCES INC | 0000950130-97-004416 ↗ |
| 1997-11-05 | S-1/A | S-1/A (amendment) | AASTROM BIOSCIENCES INC | 0001012870-97-002143 ↗ |
| 1997-11-20 | S-1/A | S-1/A (amendment) | AASTROM BIOSCIENCES INC | 0001012870-97-002330 ↗ |
| 1997-11-21 | S-1/A | S-1/A (amendment) | AASTROM BIOSCIENCES INC | 0001012870-97-002340 ↗ |
| 1997-11-25 | S-1/A | S-1/A (amendment) | AASTROM BIOSCIENCES INC | 0001012870-97-002356 ↗ |
| 1997-11-26 | 424B4 | 424B4 (final prospectus) | AASTROM BIOSCIENCES INC | 0001012870-97-002367 ↗ |
| 2008-11-24 | EFFECT | EFFECT (declared effective) | AASTROM BIOSCIENCES INC | 9999999995-08-003502 ↗ |
| 2008-11-26 | EFFECT | EFFECT (declared effective) | AASTROM BIOSCIENCES INC | 9999999995-08-003515 ↗ |
| 2009-03-19 | EFFECT | EFFECT (declared effective) | AASTROM BIOSCIENCES INC | 9999999995-09-000664 ↗ |
| 2009-06-17 | S-1 | S-1 (registration) | AASTROM BIOSCIENCES INC | 0000950123-09-014737 ↗ |
| 2009-06-29 | EFFECT | EFFECT (declared effective) | AASTROM BIOSCIENCES INC | 9999999995-09-001801 ↗ |
| 2010-04-12 | EFFECT | EFFECT (declared effective) | AASTROM BIOSCIENCES INC | 9999999995-10-001009 ↗ |
| 2010-11-29 | EFFECT | EFFECT (declared effective) | AASTROM BIOSCIENCES INC | 9999999995-10-003395 ↗ |
| 2011-07-18 | EFFECT | EFFECT (declared effective) | AASTROM BIOSCIENCES INC | 9999999995-11-002163 ↗ |
| 2012-03-30 | EFFECT | EFFECT (declared effective) | AASTROM BIOSCIENCES INC | 9999999995-12-000900 ↗ |
| 2013-04-29 | S-1 | S-1 (registration) | AASTROM BIOSCIENCES INC | 0001104659-13-033806 ↗ |
| 2013-05-13 | S-1/A | S-1/A (amendment) | AASTROM BIOSCIENCES INC | 0001104659-13-040568 ↗ |
| 2013-07-25 | S-1/A | S-1/A (amendment) | AASTROM BIOSCIENCES INC | 0001104659-13-056497 ↗ |
| 2013-08-08 | S-1/A | S-1/A (amendment) | AASTROM BIOSCIENCES INC | 0001104659-13-061769 ↗ |
| 2013-08-12 | S-1/A | S-1/A (amendment) | AASTROM BIOSCIENCES INC | 0001104659-13-062823 ↗ |
| 2013-08-13 | S-1/A | S-1/A (amendment) | AASTROM BIOSCIENCES INC | 0001104659-13-062903 ↗ |
| 2013-08-13 | S-1/A | S-1/A (amendment) | AASTROM BIOSCIENCES INC | 0001104659-13-062989 ↗ |
| 2013-08-13 | EFFECT | EFFECT (declared effective) | AASTROM BIOSCIENCES INC | 9999999995-13-002393 ↗ |
| 2014-02-10 | S-1 | S-1 (registration) | AASTROM BIOSCIENCES INC | 0001104659-14-008107 ↗ |
| 2014-03-26 | S-1/A | S-1/A (amendment) | AASTROM BIOSCIENCES INC | 0001104659-14-022982 ↗ |
| 2014-04-03 | EFFECT | EFFECT (declared effective) | AASTROM BIOSCIENCES INC | 9999999995-14-000868 ↗ |
| 2014-08-06 | S-1 | S-1 (registration) | AASTROM BIOSCIENCES INC | 0001104659-14-057562 ↗ |
| 2014-09-02 | S-1/A | S-1/A (amendment) | AASTROM BIOSCIENCES INC | 0001047469-14-007286 ↗ |
| 2014-09-08 | S-1/A | S-1/A (amendment) | AASTROM BIOSCIENCES INC | 0001047469-14-007454 ↗ |
| 2014-09-10 | EFFECT | EFFECT (declared effective) | AASTROM BIOSCIENCES INC | 9999999995-14-002718 ↗ |
| 2014-09-11 | 424B4 | 424B4 (final prospectus) | AASTROM BIOSCIENCES INC | 0001047469-14-007564 ↗ |
| 2015-07-15 | EFFECT | EFFECT (declared effective) | Vericel Corp | 9999999995-15-001917 ↗ |
| 2015-07-15 | EFFECT | EFFECT (declared effective) | Vericel Corp | 9999999995-15-001918 ↗ |
| 2015-07-15 | EFFECT | EFFECT (declared effective) | Vericel Corp | 9999999995-15-001930 ↗ |
| 2015-07-15 | EFFECT | EFFECT (declared effective) | Vericel Corp | 9999999995-15-001931 ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| ZERBE ROBERT L MD | Director | 43 | 2006–2026 | ||
| SIMS NELSON M | Director | 16 | 2006–2015 | ||
| ARMSTRONG R DOUGLAS PHD | Director; Officer | CEO and Chairman of the Board; Chairman and CEO | 3 | 2006 | |
| Brennan Gerald JR | Officer | VP Admin. and Finance, CFO; VP Admin. & Finance, CFO | 7 | 2006–2007 | |
| Hock Janet Mary | Officer | VP Global Research & CSO | 1 | 2006 | |
| SUDOVAR STEPHEN | Director | 6 | 2006–2008 | ||
| DUNBAR GEORGE W JR | Director; Director,Officer; Officer | CEO and President; CEO, President and Director; President & CEO | 10 | 2006–2010 | |
| BARD ROBERT | Officer | VP Reg-Clinic Affairs &, QS. | 1 | 2006 | |
| HAMPSON BRIAN | Officer | VP Product Development | 1 | 2006 | |
| Elmar Burchardt | Officer | VP Medical Affiars | 1 | 2006 | |
| Bartel Ronnda | Officer | Chief Scientific Officer; VP Research & Development | 8 | 2006–2012 | |
| Rubino Alan L | Director | 31 | 2006–2026 | ||
| WYANT SUSAN | Director | 2 | 2006–2007 | ||
| MAYLEBEN TIMOTHY M | Director; Director,Officer | CEO and President; CEO & President; CEO, President and Director; CEO, President, CFO & Director; President and CEO | 18 | 2006–2012 | |
| Urschel Harold C Jr | Director | 8 | 2009–2012 | ||
| Durbin Scott | Officer | CFO; CFO and Treasurer; Chief Financial Officer | 8 | 2010–2012 | |
| CRESSWELL RONALD M | Director | 8 | 2010–2013 | ||
| Watling Sharon | Officer | Vice President; VP Clinical Development | 4 | 2011–2012 | |
| Gibson Brian | Officer | Vice President | 3 | 2011–2012 | |
| Orlando Daniel | Officer | Chief Operating Officer; Interim CEO | 14 | 2012–2020 | |
| Colangelo Dominick | Director,Officer | President and CEO | 61 | 2013–2026 | |
| DART KENNETH BRYAN | TenPercentOwner | 2 | 2013–2014 | ||
| Eastern Capital LTD | TenPercentOwner | 2 | 2013–2014 | ||
| Portfolio Services Ltd. | TenPercentOwner | 2 | 2013–2014 | ||
| Elliston Michael W. | Officer | Controller | 2 | 2013–2014 | |
| Hagen Heidi | Director | 21 | 2013–2026 | ||
| MICHEL GERARD J | Officer | CFO and VP, Corp. Development; CFO & VP , Corp. Development | 27 | 2014–2020 | |
| BLUTT MITCHELL J MD | Other; TenPercentOwner | 4 | 2014–2016 | ||
| Consonance Capital Management LP | Other; TenPercentOwner | 4 | 2014–2016 | ||
| Consonance Capman GP, LLC | Other; TenPercentOwner | 4 | 2014–2016 | ||
| GILMAN STEVEN C | Director | 24 | 2015–2024 | ||
| MCLAUGHLIN KEVIN F | Director | 24 | 2015–2026 | ||
| Wotton Paul K | Director | 23 | 2015–2026 | ||
| Halpin Michael | Officer | Chief Operating Officer | 40 | 2019–2026 | |
| Flynn Sean C. | Officer | Chief Legal Officer; SVP, General Counsel; VP, General Counsel | 28 | 2020–2026 | |
| Hopper Jonathan Mark | Officer | Chief Medical Officer | 37 | 2020–2026 | |
| Pennell Sandra | Officer | VP and Corporate Controller | 1 | 2020 | |
| Mara Joseph Anthony Jr | Officer | Chief Financial Officer | 23 | 2021–2026 | |
| WRIGHT LISA | Director | 11 | 2021–2026 | ||
| SIEGAL JONATHAN | Officer | Principal Accounting Officer | 26 | 2022–2026 | |
| Mahoney Karen | Officer | Chief Human Resources Officer | 4 | 2025 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2012-03-23 | AASTROM BIOSCIENCES INC | Biotechnology | $40,001,000 | $40,001,000 | 1 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.